Understanding IUI Treatment
Learn from our experts and get inspired by real patient journeys
There is a heartbreaking reality in IVF that no one prepares couples for. A Grade AA blastocyst — the highest embryology grade — is carefully transferred into a perfectly prepared uterus. The embryologist says, ‘This one looks excellent.’ And yet, the cycle fails. Or worse, a pregnancy begins and ends in an early miscarriage.
The question couples ask — ‘Why? What went wrong?’ — often has a single, invisible answer: the chromosome count inside that perfect-looking embryo was abnormal.
A microscope can assess what an embryo looks like. It cannot assess what an embryo contains at the chromosomal level. An embryo with Trisomy 21 will grade identically to a chromosomally normal one under conventional morphological grading.
The term ‘Preimplantation Genetic Testing’ covers two different tests addressing two different clinical problems:
Full name: Preimplantation Genetic Testing for Aneuploidies
What it tests: All 46 chromosomes via NGS. Identifies euploid (normal) vs aneuploid (abnormal) embryos.
Who it is for: Women aged 35+, recurrent IVF failure, recurrent miscarriage, high sperm DNA fragmentation, prior chromosomally abnormal pregnancy.
Primary benefit: Transfer only chromosomally verified embryos — reducing miscarriage and improving live birth rates per transfer.
Full name: Preimplantation Genetic Testing for Monogenic Diseases
What it tests: A specific, pre-identified gene mutation. A custom genetic probe must be designed before the IVF cycle begins.
Who it is for: Carriers of Thalassemia, SMA, Sickle Cell, Huntington’s, BRCA1/2, Cystic Fibrosis, Fragile-X.
Primary benefit: Prevents transmission of known serious genetic disease to the child. Regulated under PCPNDT Act 1994.
| Feature | PGT-A (PGS) | PGT-M (PGD) |
|---|---|---|
| What it tests | Chromosome number — all 46 screened | Specific inherited gene mutation |
| Technology | Next-Generation Sequencing (NGS) | Custom PCR + NGS probe design |
| Who it is for | Advanced age, recurrent failure, recurrent miscarriage | Carriers of known hereditary conditions |
| Pre-cycle preparation | Minimal — standard IVF workup | Extensive — custom probe design (4–8 weeks) |
| Biopsy timing | Day 5 Blastocyst trophectoderm biopsy | Day 5 Blastocyst trophectoderm biopsy |
| Requires freeze-all? | Yes — results take 10–21 days | Yes — mandatory FET cycle |
| Sex selection? | ILLEGAL — PCPNDT Act 1994 | ILLEGAL — PCPNDT Act 1994 |
| Primary benefit | Reduces failed transfers and miscarriage | Prevents child inheriting genetic disease |




Egg quality declines significantly with age. By age 40, more than 60% of embryos may carry chromosomal abnormalities. PGT-A identifies the viable embryos within the cohort — saving time, cycles, and emotional resources.
When morphologically good embryos repeatedly fail to implant, chromosomal abnormality is a primary undiagnosed cause. PGT-A determines whether the problem is genetic — before investing in another complete cycle.
Approximately 50–60% of first-trimester miscarriages result from chromosomal aneuploidy. PGT-A dramatically reduces recurrence risk by ensuring only euploid embryos are transferred.
A prior pregnancy with Down Syndrome (Trisomy 21), Edwards Syndrome, Patau Syndrome, or other chromosomal conditions indicates elevated risk. PGT-A substantially reduces recurrence probability.
Significant sperm DNA damage (high DFI score) is associated with higher rates of chromosomal errors in embryos after fertilisation. PGT-A provides an additional verification layer.
Couples with confirmed Thalassemia, Sickle Cell, SMA, Huntington’s Disease, BRCA mutations, or other single-gene disorders should discuss PGT-M with Dr. Shah to prevent disease transmission.
Important Note: PGT does not improve egg quality or create better embryos. Its purpose is accurate selection — identifying the embryo with the highest biological probability of a healthy live birth from the embryos already available. Dr. Pranay Shah will only advise PGT when it is clinically appropriate.
Dr. Pranay Shah reviews your complete clinical history — age, previous IVF outcomes, miscarriage history, family genetic conditions. He confirms whether PGT-A or PGT-M is indicated and discusses realistic expectations, transparent costs, and the requirement for a freeze-all cycle.
A standard controlled ovarian stimulation protocol is followed. The goal is to retrieve an adequate number of mature eggs. Having multiple embryos is advantageous — a larger cohort increases the probability of finding at least one euploid embryo.
Eggs are fertilised using ICSI (Intracytoplasmic Sperm Injection). Embryos are cultured to the blastocyst stage (Day 5 or Day 6). Only blastocysts of adequate quality proceed to biopsy. Day 3 biopsy has been largely abandoned globally.
The embryologist uses a precision laser-assisted system to remove 4–6 cells from the trophectoderm — the outer layer that becomes the placenta. The inner cell mass (which forms the baby) is completely undisturbed. This procedure is safe and validated across thousands of cycles globally.
Immediately after biopsy, all embryos are vitrified (flash-frozen). A fresh transfer is not possible — genetic results take 10–21 days. All embryos are stored safely until results are received.
Biopsied cells are analysed at our partnered NABL-accredited genetics laboratory. NGS screens all 24 chromosome types, categorising each embryo as: Euploid (normal — suitable for transfer) | Aneuploid (abnormal — not suitable) | Mosaic (mixed — requires counselling).
Once results are received, Dr. Pranay Shah personally consults the couple. In the next prepared Frozen Embryo Transfer (FET) cycle, the highest-quality euploid embryo is carefully thawed and transferred under ultrasound guidance.
After 5 years of marriage and visiting many places, when we came here, we decided on the right guidance here that we will get the ivf procedure done from here, today we have 10 days of treatment. Due to the convenience, arrangement and facility o...
My experience with wellspring hospital is very good .their staff is very supportive. Dr. Pranay is very good and professional.100% transparency at every stage. No last minute surprises.Once again thank you so much to the all team. Highlly recomme...
Wellspring IVF & women hospital is one of the best IVF center in India where me like other infertile Indian and foreigner couples fulfill their dreams of having a healthy baby.Dr Pranay Shah has deep knowledge and skill in his work with positive ...
Such a nice experience at well spring. And we get A childhope from this well spring hospital. Thanks a lot all members of hospital and specially to Dr. Pranay Shah sir
This is one of the best ivf clinic in Ahemdabad, Dr.Pranay shah and his team are highly professional and knowledgeable, and his staff members are too good and supportive. Dr. Pranay shah is result oriented and confident, and gives right instructi...
We were facing some difficulties related pregnancy and we got reference of Wellspring Hospital. We thank God that we found such a talented and knowledgeable Dr. Pranay Sir. The most thing we like about him is the way of treatment he follows. I str...
I've been blessed with two daughters by the treatment given by Dr. Pranay Shah the services given to me were comforting and caring.
This is one of the best hospital in ivf treatment with highest possibility of success, best supportive doctor and staff, thanks and recommended all to visit once
No words are enough to express my gratitude . Thank you for making our dream comes true. You are extraordinary doctor as well as extraordinary human being also.Again thank you so much Dr.Pranay Shah and your team. Best ever doctor I have meet in ...
Great experience with great doctor and very supportive after care facilities. Dr. Shah was not only helpful with numerous questions that we asked for around 6 months before we started the treatment but is also helping us now. He has been very help...
We were looking for a good fertility center we came across some good reviews of Wellspring Spring Ivf Hospital. We decided and visited the hospital and with in no time the process was completed and in first attempt only the result was positive?. ...
It has been one of the best choices that I could have made. Since researching Wellspring on Google till now the end of complete IVF cycle it has been a wonderful experience. I could have gone to biggies referential IVF Centres but I am sure experi...
We had been very desperate to have a child. Visited many IVF centers in India for treatment. But did not get any positive result. Visited the Best IVF Center in Ahmedabad Wellspring IVF and Women's hospital after seeing good reviews. Happy to sa...
Wellspring IVF & Women's Hospital is best IVF Center in Ahmedabad. Best thing, we got positive result in Fist IVF Cycle. Second best thing, Doctor has told us exact amount of Cost of each IVF Cycle before start of treatment so there would be no en...
Me and my husband are very glad we chose to come here for treatment. I would highly recommend Dr. Shah and his team at the Wellspring IVF and Women's hospital to anyone wanting to reach their dream of becoming parents. His medical knowledge and p...
No words are enough to express my gratitude . Thank you for making our dream comes true. You are extraordinary doctor as well as extraordinary human being also.Again thank you so much Dr.Pranay Shah and your team.
Excellent IVF Center. Friendly nature all staff & Doctor. Excellent Treatment for the Doctor. Thanks Wellspring IVF Fullfil our Dreams.
What to say about dr pranay sir Very good human being along with very good doctor Always showers positivity on us Solves every small small queries with open heart and big smile Approachable 24*7 I will suggest everyone to consult at least once if ...
| Genetic Condition | Inheritance | Relevance for Gujarat / India |
|---|---|---|
| Beta-Thalassemia Major | Autosomal Recessive | One of the most prevalent inherited blood disorders in Gujarat. Carrier couples face a 25% risk of a severely affected child per pregnancy. |
| Sickle Cell Disease | Autosomal Recessive | HBB gene mutation. High carrier frequency in tribal and certain communities across Gujarat. |
| Who it is for | Advanced age, recurrent failure, recurrent miscarriage | Carriers of known hereditary conditions |
| Pre-cycle preparation | Minimal — standard IVF workup | Extensive — custom probe design (4–8 weeks) |
| Biopsy timing | Day 5 Blastocyst trophectoderm biopsy | Day 5 Blastocyst trophectoderm biopsy |
| Requires freeze-all? | Yes — results take 10–21 days | Yes — mandatory FET cycle |
| Sex selection? | ILLEGAL — PCPNDT Act 1994 | ILLEGAL — PCPNDT Act 1994 |
| Primary benefit | Reduces failed transfers and miscarriage | Prevents child inheriting genetic disease |
| Fragile-X Syndrome | X-Linked | FMR1 gene CGG expansion — leading genetic cause of intellectual disability. PGT-M prevents transmission. |
| Duchenne Muscular Dystrophy | X-Linked Recessive | DMD gene mutation. Carrier mothers can use PGT-M to select unaffected embryos for transfer. |
|
Patient Profile |
Aneuploidy Rate Without PGT |
Benefit of PGT-A |
Dr. Shah’s Recommendation |
|---|---|---|---|
|
Women aged 35–37 |
40–50% of embryos aneuploid |
Identifies euploid embryos; faster time-to-pregnancy |
Recommended |
|
Women aged 38–40 |
55–65% of embryos aneuploid |
Identifies the viable minority in the cohort |
Strongly Recommended |
|
Women aged 41 and above |
70–80% of embryos aneuploid |
Critical selection; informs donor egg decision |
Strongly Recommended |
|
Recurrent implantation failure |
Chromosomal cause often undetected |
Reveals if genetics is the root cause |
Strongly Recommended |
|
Recurrent miscarriage |
High aneuploidy rate in embryos |
Euploid transfer: 10–15% vs 25–40% miscarriage rate |
Strongly Recommended |
|
Women under 35, first cycle, good response |
20–30% of embryos aneuploid |
Marginal benefit; many euploid embryos naturally available |
Not routinely recommended |
Modern Day 5 trophectoderm biopsy is considered very safe. Cells removed are from the trophectoderm (future placenta), not the inner cell mass (which forms the baby). Multiple peer-reviewed studies confirm no difference in birth defect rates between children born from biopsied versus non-biopsied embryos. Performed exclusively by senior embryologists at Wellspring IVF.
PGT-A costs are additional to the IVF cycle cost. The total depends on the number of embryos biopsied and the genetics laboratory. Dr. Pranay Shah provides a fully transparent cost breakdown during consultation — in line with Wellspring IVF’s No Hidden Costs philosophy. Call 9099946050 for current pricing.
Technically yes, but this requires careful discussion. With only one or two embryos, PGT-A may reveal both are aneuploid — leaving no embryo to transfer. With a larger cohort (5+ blastocysts), PGT-A reliably identifies the best candidate. Dr. Shah will advise whether your cohort size justifies testing.
This is emotionally difficult, but clinically important information. It confirms chromosomal quality is the core issue — and prevents multiple futile transfers or miscarriages. The pathway typically involves another stimulation cycle with a modified protocol, and if indicated, an honest consultation about donor egg options.
Absolutely not. Sex selection for non-medical reasons is a criminal offence under the PCPNDT Act 1994, punishable by imprisonment and financial penalties. Wellspring IVF will never discuss, offer, or perform any procedure for sex selection. Any such request will be firmly refused.
No. Euploid means correct chromosome number — the single largest cause of implantation failure addressed by PGT-A. However, a successful pregnancy also depends on uterine receptivity, endometrial quality, immune factors, and progesterone support. PGT-A gives each transfer the highest possible biological probability of success.
PGT-M requires significant preparation. A custom genetic probe must be designed for your family’s mutation — typically taking 4–8 weeks before the IVF cycle can begin. Early consultation with Dr. Shah is essential if you carry a known hereditary condition.